Expansion of Enduring Infrastructure to Support Lung Cancer Screening Research
Summary
This is a questionnaire study. The data obtained from this study will improve our understanding of the factors that are associated with an increased risk of lung cancer and may lead to new ways to screen and prevent lung cancer.
Objective
Our long term objective is to establish a high throughput radiomics lung cancer screening pipeline that will extract radiomic features from CT images in real time. To reach this objective this protocol will prospectively consent and follow up lung cancer screening patients at the Moffitt Cancer Center and Moffitt International Plaza. The overarching goal of this research is to test the hypothesis that radiomic features derived from CT screening images alone, and in combination with risk factor and genetic data, are predictive of lung cancer risk in a lung screening population.
If you are interested in learning more about clinical trials, our clinical trial navigators can discuss your options and recommend opportunities that may be suitable for you. Call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.
Please call 1-888-663-3488 for support from a Moffitt representative. New Patients and Healthcare Professionals can submit an online form by selecting the appropriate button below. Existing patients can call 1-888-663-3488. Click here for a current list of insurances accepted at Moffitt.
NEW PATIENTS To request a new patient appointment, please fill out the online form or call 1-888-663-3488.
REFERRING PHYSICIANS Providers and medical staff can refer patients by submitting our online referral form.
Moffit now offers Virtual Visits for patients. If you are eligible for a virtual appointment, our scheduling team will discuss this option further with you.
Moffitt Cancer Center is committed to the health and safety of our patients and their families. For more information on how we’re protecting our new and existing patients, visit our COVID-19 Info Hub